Harbin Pharmaceutical Group Co., Ltd. 600664.SS Stock
Harbin Pharmaceutical Group Co., Ltd. Price Chart
Harbin Pharmaceutical Group Co., Ltd. 600664.SS Financial and Trading Overview
| Harbin Pharmaceutical Group Co., Ltd. stock price | 2.84 CNY |
| Previous Close | 3.4 CNY |
| Open | 3.41 CNY |
| Bid | 3.38 CNY x 0 |
| Ask | 3.39 CNY x 0 |
| Day's Range | 3.37 - 3.43 CNY |
| 52 Week Range | 2.56 - 3.95 CNY |
| Volume | 22.8M CNY |
| Avg. Volume | 39.64M CNY |
| Market Cap | 8.56B CNY |
| Beta (5Y Monthly) | 0.275544 |
| PE Ratio (TTM) | 17.842106 |
| EPS (TTM) | 0.16 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 4, 2018 |
| 1y Target Est | N/A |
600664.SS Valuation Measures
| Enterprise Value | 9.08B CNY |
| Trailing P/E | 17.842106 |
| Forward P/E | 15.409091 |
| PEG Ratio (5 yr expected) | 1.16 |
| Price/Sales (ttm) | 0.59387994 |
| Price/Book (mrq) | 1.9206799 |
| Enterprise Value/Revenue | 0.63 |
| Enterprise Value/EBITDA | 11.405 |
Trading Information
Harbin Pharmaceutical Group Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.275544 |
| 52-Week Change | 14.86% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.95 CNY |
| 52 Week Low | 2.56 CNY |
| 50-Day Moving Average | 3.41 CNY |
| 200-Day Moving Average | 3.11 CNY |
600664.SS Share Statistics
| Avg. Volume (3 month) | 39.64M CNY |
| Avg. Daily Volume (10-Days) | 28.94M CNY |
| Shares Outstanding | 2.52B |
| Float | 1.32B |
| Short Ratio | N/A |
| % Held by Insiders | 53.67% |
| % Held by Institutions | 0.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 13:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 3.37% |
| Operating Margin (ttm) | 3.81% |
| Gross Margin | 24.68% |
| EBITDA Margin | 5.52% |
Management Effectiveness
| Return on Assets (ttm) | 2.61% |
| Return on Equity (ttm) | 11.24% |
Income Statement
| Revenue (ttm) | 14.41B CNY |
| Revenue Per Share (ttm) | 5.93 CNY |
| Quarterly Revenue Growth (yoy) | 17.89% |
| Gross Profit (ttm) | 3.41B CNY |
| EBITDA | 795.73M CNY |
| Net Income Avi to Common (ttm) | 486.21M CNY |
| Diluted EPS (ttm) | 0.19 |
| Quarterly Earnings Growth (yoy) | 21.69% |
Balance Sheet
| Total Cash (mrq) | 2.42B CNY |
| Total Cash Per Share (mrq) | 0.96 CNY |
| Total Debt (mrq) | 2.08B CNY |
| Total Debt/Equity (mrq) | 40.83 CNY |
| Current Ratio (mrq) | 1.22 |
| Book Value Per Share (mrq) | 1.765 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 649.84M CNY |
| Levered Free Cash Flow (ttm) | 543.58M CNY |
Profile of Harbin Pharmaceutical Group Co., Ltd.
| Country | China |
| State | N/A |
| City | Harbin |
| Address | No. 7, Qunli Avenue |
| ZIP | 150070 |
| Phone | 400 900 1111 |
| Website | https://www.hayao.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10064 |
Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company's lead products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsule, Shuanghuanglian oral solution, alprostadil injection, Namin granules, lacidipine tablets, cefotiam hydrochloride for injection, ibuprofen granules, Xingaizhonggai high calcium tablets, etc., as well as paracetamol yellow for children. It also offers drugs for blood and hematopoietic, antineoplastic and immunomodulatory, respiratory, anti-inflammatory and analgesic, and chronic diseases, as well as minerals, Chinese medicines, and antibiotics. The company offers its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. The company is based in Harbin, China.
Q&A For Harbin Pharmaceutical Group Co., Ltd. Stock
What is a current 600664.SS stock price?
Harbin Pharmaceutical Group Co., Ltd. 600664.SS stock price today per share is 2.84 CNY.
How to purchase Harbin Pharmaceutical Group Co., Ltd. stock?
You can buy 600664.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Harbin Pharmaceutical Group Co., Ltd.?
The stock symbol or ticker of Harbin Pharmaceutical Group Co., Ltd. is 600664.SS.
Which industry does the Harbin Pharmaceutical Group Co., Ltd. company belong to?
The Harbin Pharmaceutical Group Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Harbin Pharmaceutical Group Co., Ltd. have in circulation?
The max supply of Harbin Pharmaceutical Group Co., Ltd. shares is 2.52B.
What is Harbin Pharmaceutical Group Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Harbin Pharmaceutical Group Co., Ltd. PE Ratio is 17.75000000 now.
What was Harbin Pharmaceutical Group Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Harbin Pharmaceutical Group Co., Ltd. EPS is 0.16 CNY over the trailing 12 months.
Which sector does the Harbin Pharmaceutical Group Co., Ltd. company belong to?
The Harbin Pharmaceutical Group Co., Ltd. sector is Healthcare.
Stocks Related By Sector
- Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Stock
- Cisen Pharmaceutical Co., Ltd. 603367.SS Stock
- Beijing Chunlizhengda Medical Instruments Co., Ltd. 688236.SS Stock
- Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 688621.SS Stock
- Youcare Pharmaceutical Group Co., Ltd. 688658.SS Stock